Tanimilast (CHF6001; CHF-6001) is a novel and potent PDE4 (phosphodiesterase 4) inhibitor (IC50=0.026 nM) with anti-inflammatory activity. It has the potential to be used for topical pulmonary administration.

纯度：≥98%

CAS：1239278-59-1